Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344–>Ser)

We investigated the genetic defects in two patients with familial lecithin:cholesterol acyltransferase (LCAT) deficiency. Their clinical manifestations including corneal opacities, anemia, proteinuria, and hypoalphalipoproteinemia were identical for familial LCAT deficiency. Their LCAT activities an...

Full description

Bibliographic Details
Main Authors: K Moriyama, J Sasaki, F Arakawa, N Takami, E Maeda, A Matsunaga, Y Takada, K Midorikawa, T Yanase, G Yoshino
Format: Article
Language:English
Published: Elsevier 1995-11-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520397145
id doaj-1195c1390265442b934bd8f931b93d68
record_format Article
spelling doaj-1195c1390265442b934bd8f931b93d682021-04-26T05:49:57ZengElsevierJournal of Lipid Research0022-22751995-11-01361123292343Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344–>Ser)K Moriyama0J Sasaki1F Arakawa2N Takami3E Maeda4A Matsunaga5Y Takada6K Midorikawa7T Yanase8G Yoshino9Department of Internal Medicine and Biochemistry, School of Medicine, Fukuoka University, Japan.Department of Internal Medicine and Biochemistry, School of Medicine, Fukuoka University, Japan.Department of Internal Medicine and Biochemistry, School of Medicine, Fukuoka University, Japan.Department of Internal Medicine and Biochemistry, School of Medicine, Fukuoka University, Japan.Department of Internal Medicine and Biochemistry, School of Medicine, Fukuoka University, Japan.Department of Internal Medicine and Biochemistry, School of Medicine, Fukuoka University, Japan.Department of Internal Medicine and Biochemistry, School of Medicine, Fukuoka University, Japan.Department of Internal Medicine and Biochemistry, School of Medicine, Fukuoka University, Japan.Department of Internal Medicine and Biochemistry, School of Medicine, Fukuoka University, Japan.Department of Internal Medicine and Biochemistry, School of Medicine, Fukuoka University, Japan.We investigated the genetic defects in two patients with familial lecithin:cholesterol acyltransferase (LCAT) deficiency. Their clinical manifestations including corneal opacities, anemia, proteinuria, and hypoalphalipoproteinemia were identical for familial LCAT deficiency. Their LCAT activities and the cholesterol esterification rate (CER) were nearly zero, and their LCAT masses were below 10% of normal control values. Sequence analysis of the amplified DNA of case 1 revealed one base deletion of G at base 873 (first position of Val264) in exon 6, leading to a premature termination by frameshift. Sequence analysis of amplified DNA of case 2 revealed a single G to A converting Gly (GGT) to Ser (AGT) substitution at residue 344. When COS-1 cells were transfected with these mutants, LCAT activity in the medium was nearly zero, and the LCAT mass was undetectable (< 0.01 microgram/ml). In contrast, LCAT activity in the medium of COS-1 cells, transfected with wild-type LCAT, was 1.7 nmol/h per ml and the LCAT mass was 0.09 micrograms/ml. The LCAT mass in the cell lysates of the mutants was less than 12% of control for case 1 and 18% of control for case 2. Northern blot analysis of the mRNA of COS-1 cells transfected with the mutants showed the same amounts of LCAT mRNA as compared with wild-type LCAT. Biosynthesis of mutant LCATs was analyzed by pulse-chase and immunocytochemistry in transfected baby hamster kidney cells. SDS-PAGE/fluorography demonstrated that wild-type LCAT was synthesized as a high-mannose type of 56 kDa, which was very slowly converted to a mature form of 67 kDa and was secreted into the media. In contrast to the wild-type LCAT, the mutant precursors were not processed into the mature form but slowly degraded along with chase times. On steady and continuous labeling in the case of wild-type LCAT, the mature 67 kDa form was observed in both the cell lysate and media, whereas no mature form was detected in the cell lysates and media which were transfected mutant LCATs. These data suggest that the mutant LCATs are actually synthesized in an amount comparable to that of wild-type, but they are slowly degraded without being processed into the mature form. The immunocytochemistry revealed that mutant LCATs were mainly retained in the endoplasmic reticulum. These data suggest that these two mutations may disrupt the mutant LCATs' transport from the endoplasmic reticulum into Golgi apparatus, resulting in LCAT deficiency.http://www.sciencedirect.com/science/article/pii/S0022227520397145
collection DOAJ
language English
format Article
sources DOAJ
author K Moriyama
J Sasaki
F Arakawa
N Takami
E Maeda
A Matsunaga
Y Takada
K Midorikawa
T Yanase
G Yoshino
spellingShingle K Moriyama
J Sasaki
F Arakawa
N Takami
E Maeda
A Matsunaga
Y Takada
K Midorikawa
T Yanase
G Yoshino
Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344–>Ser)
Journal of Lipid Research
author_facet K Moriyama
J Sasaki
F Arakawa
N Takami
E Maeda
A Matsunaga
Y Takada
K Midorikawa
T Yanase
G Yoshino
author_sort K Moriyama
title Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344–>Ser)
title_short Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344–>Ser)
title_full Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344–>Ser)
title_fullStr Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344–>Ser)
title_full_unstemmed Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344–>Ser)
title_sort two novel point mutations in the lecithin:cholesterol acyltransferase (lcat) gene resulting in lcat deficiency: lcat (g873 deletion) and lcat (gly344–>ser)
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 1995-11-01
description We investigated the genetic defects in two patients with familial lecithin:cholesterol acyltransferase (LCAT) deficiency. Their clinical manifestations including corneal opacities, anemia, proteinuria, and hypoalphalipoproteinemia were identical for familial LCAT deficiency. Their LCAT activities and the cholesterol esterification rate (CER) were nearly zero, and their LCAT masses were below 10% of normal control values. Sequence analysis of the amplified DNA of case 1 revealed one base deletion of G at base 873 (first position of Val264) in exon 6, leading to a premature termination by frameshift. Sequence analysis of amplified DNA of case 2 revealed a single G to A converting Gly (GGT) to Ser (AGT) substitution at residue 344. When COS-1 cells were transfected with these mutants, LCAT activity in the medium was nearly zero, and the LCAT mass was undetectable (< 0.01 microgram/ml). In contrast, LCAT activity in the medium of COS-1 cells, transfected with wild-type LCAT, was 1.7 nmol/h per ml and the LCAT mass was 0.09 micrograms/ml. The LCAT mass in the cell lysates of the mutants was less than 12% of control for case 1 and 18% of control for case 2. Northern blot analysis of the mRNA of COS-1 cells transfected with the mutants showed the same amounts of LCAT mRNA as compared with wild-type LCAT. Biosynthesis of mutant LCATs was analyzed by pulse-chase and immunocytochemistry in transfected baby hamster kidney cells. SDS-PAGE/fluorography demonstrated that wild-type LCAT was synthesized as a high-mannose type of 56 kDa, which was very slowly converted to a mature form of 67 kDa and was secreted into the media. In contrast to the wild-type LCAT, the mutant precursors were not processed into the mature form but slowly degraded along with chase times. On steady and continuous labeling in the case of wild-type LCAT, the mature 67 kDa form was observed in both the cell lysate and media, whereas no mature form was detected in the cell lysates and media which were transfected mutant LCATs. These data suggest that the mutant LCATs are actually synthesized in an amount comparable to that of wild-type, but they are slowly degraded without being processed into the mature form. The immunocytochemistry revealed that mutant LCATs were mainly retained in the endoplasmic reticulum. These data suggest that these two mutations may disrupt the mutant LCATs' transport from the endoplasmic reticulum into Golgi apparatus, resulting in LCAT deficiency.
url http://www.sciencedirect.com/science/article/pii/S0022227520397145
work_keys_str_mv AT kmoriyama twonovelpointmutationsinthelecithincholesterolacyltransferaselcatgeneresultinginlcatdeficiencylcatg873deletionandlcatgly344ser
AT jsasaki twonovelpointmutationsinthelecithincholesterolacyltransferaselcatgeneresultinginlcatdeficiencylcatg873deletionandlcatgly344ser
AT farakawa twonovelpointmutationsinthelecithincholesterolacyltransferaselcatgeneresultinginlcatdeficiencylcatg873deletionandlcatgly344ser
AT ntakami twonovelpointmutationsinthelecithincholesterolacyltransferaselcatgeneresultinginlcatdeficiencylcatg873deletionandlcatgly344ser
AT emaeda twonovelpointmutationsinthelecithincholesterolacyltransferaselcatgeneresultinginlcatdeficiencylcatg873deletionandlcatgly344ser
AT amatsunaga twonovelpointmutationsinthelecithincholesterolacyltransferaselcatgeneresultinginlcatdeficiencylcatg873deletionandlcatgly344ser
AT ytakada twonovelpointmutationsinthelecithincholesterolacyltransferaselcatgeneresultinginlcatdeficiencylcatg873deletionandlcatgly344ser
AT kmidorikawa twonovelpointmutationsinthelecithincholesterolacyltransferaselcatgeneresultinginlcatdeficiencylcatg873deletionandlcatgly344ser
AT tyanase twonovelpointmutationsinthelecithincholesterolacyltransferaselcatgeneresultinginlcatdeficiencylcatg873deletionandlcatgly344ser
AT gyoshino twonovelpointmutationsinthelecithincholesterolacyltransferaselcatgeneresultinginlcatdeficiencylcatg873deletionandlcatgly344ser
_version_ 1721508369467965440